James M Brophy1. 1. Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. james.brophy@mcgill.ca
Abstract
OBJECTIVE: To assess the relative importance that cardiovascular specialists assign to new technologies. METHODS: A pilot survey of practising cardiologists in one tertiary hospital and cardiology trainees from two university programs. Respondents were asked to distribute a hypothetical budget among several new technologies. RESULTS: A total of 28 responses (response rate of 62%) were analyzed. In the hypothetical situation described, doctors appeared willing to spend approximately equal amounts on implantable cardiac defibrillators (median 25%, interquartile range 5% to 30%) and bare metal coronary stents (median 28%, interquartile range 20% to 40%). Physicians were more restrained in their allocation for refinements of these two technologies, including drug-eluting stents and biventricular pacing. Wide individual variations in technology use were noted. CONCLUSIONS: There is considerable uncertainty among cardiovascular specialists regarding the relative value of new technologies. Further work is required to better quantify this uncertainty and its determinants.
OBJECTIVE: To assess the relative importance that cardiovascular specialists assign to new technologies. METHODS: A pilot survey of practising cardiologists in one tertiary hospital and cardiology trainees from two university programs. Respondents were asked to distribute a hypothetical budget among several new technologies. RESULTS: A total of 28 responses (response rate of 62%) were analyzed. In the hypothetical situation described, doctors appeared willing to spend approximately equal amounts on implantable cardiac defibrillators (median 25%, interquartile range 5% to 30%) and bare metal coronary stents (median 28%, interquartile range 20% to 40%). Physicians were more restrained in their allocation for refinements of these two technologies, including drug-eluting stents and biventricular pacing. Wide individual variations in technology use were noted. CONCLUSIONS: There is considerable uncertainty among cardiovascular specialists regarding the relative value of new technologies. Further work is required to better quantify this uncertainty and its determinants.
Authors: Michael Pignone; Somnath Saha; Tom Hoerger; Kathleen N Lohr; Steven Teutsch; Jeanne Mandelblatt Journal: Ann Intern Med Date: 2005-06-21 Impact factor: 25.391
Authors: Sana M Al-Khatib; Gillian D Sanders; Daniel B Mark; Kerry L Lee; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Stuart Connolly; Alan Kadish; Arthur Moss; Arthur M Feldman; Kenneth A Ellenbogen; Steven Singh; Robert M Califf Journal: Am Heart J Date: 2005-06 Impact factor: 4.749
Authors: Mohan N Babapulle; Lawrence Joseph; Patrick Bélisle; James M Brophy; Mark J Eisenberg Journal: Lancet Date: 2004 Aug 14-20 Impact factor: 79.321